Research Integrity & Misconduct

The document provides an in-depth guide for institutions on incorporating the 2024 Public Health Service (PHS) Research Misconduct Rule (42 CFR Part 93) into their research misconduct policies and procedures. It emphasizes the new flexibilities introduced in the 2024 Rule and outlines key decision points institutions must consider, such as the distinction between what is established in policy vers

The document outlines recent updates to the U.S. Public Health Service (PHS) Policies on Research Misconduct as administered by the Department of Health and Human Services' Office of Research Integrity (ORI). The key changes, encapsulated in the 2024 Final Rule, aim to provide a more transparent, responsive, and adaptable framework for addressing research misconduct in the evolving research l

The Office of Research Integrity (ORI), under the leadership of Director Sheila Garrity, oversees the enforcement and promotion of research integrity within institutions funded by the U.S. Department of Health and Human Services. The Division of Education and Integrity manages approximately 6,000 institutional assurances, reviews policies and procedures related to research misconduct, conducts com

The document outlines the U.S. federal government’s comprehensive framework for scientific integrity, as developed by the U.S. Geological Survey, the Environmental Protection Agency, and the National Science and Technology Council (NSTC) Subcommittee on Scientific Integrity. The framework sets out clear objectives to strengthen a culture of scientific integrity across federal agencies, emphasizing

The document details the significant research misconduct incident at Duke University that led to a $112.5 million settlement with the federal government following allegations under the False Claims Act. It outlines how a research technician’s data fabrication between 2006 and 2013 impacted numerous federally funded grants and resulted in multiple paper retractions. The case highlighted deficiencie

The document provides an update from the Office of Research Integrity (ORI) under the Office of the Assistant Secretary for Health, outlining its structure, responsibilities, and current initiatives as presented at a 2019 COGR meeting. The ORI is organized into three divisions: the Office of the Director, the Division of Investigative Oversight, and the Division of Education & Integrity. It is

The document, authored by Shai D. Silberberg of the National Institute of Neurological Disorders and Stroke at the NIH, addresses challenges and initiatives related to strengthening research rigor and reproducibility in biomedical science. It highlights the prevalence of scientific malpractice and inadequate methodological reporting, citing increases in article retractions and the influence of bia

The document, authored by Brian Nosek of the University of Virginia's Center for Open Science, addresses the challenge of improving openness and reproducibility in scientific research. It contrasts scientific norms—such as openness, universalism, disinterestedness, and organized skepticism—with prevalent counternorms like secrecy, particularism, self-interestedness, and organized dogmatism, w

The document is a summary of a panel discussion led by Joan Ferrini-Mundy, then Chief Operating Officer of the National Science Foundation (NSF), addressing the NSF's perspectives on fostering integrity in research as highlighted in the National Academy of Sciences' "Fostering Integrity in Research" report. The NSF's substantial financial investment in research and educati